Oxidative Damage Is the Earliest Event in Alzheimer Disease

Recently, we demonstrated a significant increase of an oxidized nucleoside derived from RNA, 8-hydroxyguanosine (8OHG), and an oxidized amino acid, nitrotyrosine in vulnerable neurons of patients with Alzheimer disease (AD). To determine whether oxidative damage is an early- or end-stage event in th...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuropathology and experimental neurology Vol. 60; no. 8; pp. 759 - 767
Main Authors NUNOMURA, AKIHIKO, PERRY, GEORGE, ALIEV, GJUMRAKCH, HIRAI, KEISUKE, TAKEDA, ATSUSHI, BALRAJ, ELIZABETH K, JONES, PAUL K, GHANBARI, HOSSEIN, WATAYA, TAKAFUMI, SHIMOHAMA, SHUN, CHIBA, SHIGERU, ATWOOD, CRAIG S, PETERSEN, ROBERT B, SMITH, MARK A
Format Journal Article
LanguageEnglish
Published Hagerstown, MD American Association of Neuropathologists, Inc 01.08.2001
Lippincott Williams & Wilkins
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recently, we demonstrated a significant increase of an oxidized nucleoside derived from RNA, 8-hydroxyguanosine (8OHG), and an oxidized amino acid, nitrotyrosine in vulnerable neurons of patients with Alzheimer disease (AD). To determine whether oxidative damage is an early- or end-stage event in the process of neurodegeneration in AD, we investigated the relationship between neuronal 8OHG and nitrotyrosine and histological and clinical variables, i.e. amyloid-β (Aβ) plaques and neurofibrillary tangles (NFT), as well as duration of dementia and apolipoprotein E (ApoE) genotype. Our findings show that oxidative damage is quantitatively greatest early in the disease and reduces with disease progression. Surprisingly, we found that increases in Aβ deposition are associated with decreased oxidative damage. These relationships are more significant in ApoE ε4 carriers. Moreover, neurons with NFT show a 40%–56% decrease in relative 8OHG levels compared with neurons free of NFT. Our observations indicate that increased oxidative damage is an early event in AD that decreases with disease progression and lesion formation. These findings suggest that AD is associated with compensatory changes that reduce damage from reactive oxygen.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-3069
1554-6578
DOI:10.1093/jnen/60.8.759